FDA finds low levels of possible carcinogen in Zantac

The FDA announced Friday that it found low levels of a possible carcinogen in Zantac and other heartburn medications.

Latest LiveNOW Stories

From the Archives

Consumer & Money

Science & Tech

Police Chases

Weather Across the Country